G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 82,511 | 51,301 | 31,476 | 45,285 | 0 |
| Cost of Goods | 7,195 | 3,748 | 2,016 | 0 | N/A |
| Gross Profit | 75,316 | 47,553 | 29,460 | 45,285 | N/A |
| Operating Expenses | 115,038 | 184,479 | 171,933 | 141,761 | 129,041 |
| Operating Income | -39,527 | -136,178 | -142,457 | -96,476 | -129,041 |
| Interest Expense | 10,038 | 10,432 | 4,667 | 1,778 | 0 |
| Other Income | 4,713 | 751 | -303 | 410 | 6,594 |
| Pre-tax Income | -44,852 | -145,859 | -147,427 | -97,844 | -122,447 |
| Income Tax | 3,115 | 1,700 | 925 | 1,410 | N/A |
| Net Income Continuous | -47,967 | -147,559 | -148,352 | -99,254 | -122,447 |
| Net Income | $-47,967 | $-147,559 | $-148,352 | $-99,254 | $-122,447 |
| EPS Basic Total Ops | -0.93 | -3.38 | -3.54 | -2.62 | -3.27 |
| EPS Basic Continuous Ops | -0.93 | -3.38 | -3.54 | -2.62 | -3.27 |
| EPS Diluted Total Ops | -0.93 | -3.38 | -3.54 | -2.62 | -3.27 |
| EPS Diluted Continuous Ops | -0.93 | -3.38 | -3.54 | -2.62 | -3.27 |
| EPS Diluted Before Non-Recurring Items | -0.93 | -3.38 | -3.54 | -2.62 | -3.27 |
| EBITDA(a) | $-37,541 | $-133,415 | $-140,875 | $-95,279 | $-128,685 |